What is Bylvay 400 μg, Hartkapseln used for?

( ARTG ) BYLVAY is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older.

What are the side effects of Bylvay 400 μg, Hartkapseln?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can Bylvay 400 μg, Hartkapseln be used during pregnancy?

( AHT ) For the active ingredient odevixibat You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Bylvay 400 μg, Hartkapseln belong to?

Bylvay 400 μg, Hartkapseln: ATC A05AX05. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Bylvay 400 μg, Hartkapseln

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

IPSEN Pharma Schweiz GmbH (CH)

ATC Code

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.